Research

Zacks Small Cap Research – DYAI: Looking Toward Product Revenues – Go Health Pro

by
Zacks Small Cap Research – DYAI: Looking Toward Product Revenues – Go Health Pro

By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) enters 2025 on the cusp of generating product revenues from its relationship with Proliant. Initially, commercialization efforts and sales will be focused on recombinant serum albumin. Further down the road, additional proteins may be added including bovine albumin, bovine transferrin … Read more

Research Reveals Data Breaches On The Rise at UK Law Firms – Go Health Pro

by
Research Reveals Data Breaches On The Rise at UK Law Firms – Go Health Pro

British legal professionals have seen a “significant surge” in data breaches, according to new research from NetDocuments, a firm that provides a cloud-based content management platform for the legal sector. The firm has described how it analysed data from the UK regulator the Information Commissioner’s Office (ICO), and discovered that the number of data breaches … Read more

Zacks Small Cap Research – UHAL: Reports 3Q FY2025 Results: Demand for self-moving equipment rentals increases YOY for the 3rd consecutive quarter after seven quarters of single-digit declines. Self-Storage continues to deliver top-line growth. Record amount of self-storage rentable sq. ft. added in last 12 months. – Go Health Pro

by
Zacks Small Cap Research – UHAL: Reports 3Q FY2025 Results: Demand for self-moving equipment rentals increases YOY for the 3rd consecutive quarter after seven quarters of single-digit declines. Self-Storage continues to deliver top-line growth. Record amount of self-storage rentable sq. ft. added in last 12 months. – Go Health Pro

By Steven Ralston, CFA NYSE:UHAL READ THE FULL UHAL RESEARCH REPORT U-Haul Holding Company (NYSE:UHAL) reported financial results for 3Q FY2025 on February 5th. Total revenues increased 3.7% to approximately $1.39 billion, primarily due to stronger revenue growth of 4.6% in the self-moving equipment rental business, along with a 7.9% increase in theself-storage segment. In … Read more

Zacks Small Cap Research – TELO Improves Balance Sheet – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. … Read more

Zacks Small Cap Research – PLX: Revisiting the Thesis – Go Health Pro

by
Zacks Small Cap Research – PLX: Revisiting the Thesis – Go Health Pro

By John Vandermosten, CFA NYSE:PLX READ THE FULL PLX RESEARCH REPORT Reasons To Own / A Compelling Idea for 2025 Protalix Biotherapeutics, Inc. (NYSE:PLX) finds itself in an enviable position as we begin 2025. The company has two approved products generating revenues and a pipeline with multiple candidates in development. Its products are produced and … Read more

x